NasdaqGS:WGSHealthcare
How GeneDx’s Securities Lawsuit and Fabric Genomics Impairment Will Impact GeneDx Holdings (WGS) Investors
Earlier in 2026, GeneDx Holdings Corp. was hit with a securities class action after reporting quarterly results that included a weaker adjusted gross margin, revenue shortfall versus estimates, lowered full‑year revenue guidance, and an impairment charge tied to its prior Fabric Genomics acquisition.
The combination of alleged disclosure failures and a write‑down on recently acquired technology raises fresh questions about GeneDx’s transparency, acquisition execution, and earnings quality...